Pharmacologic stress versus maximal-exercise stress for perfusion imaging: Which, when, and why?

Journal of Nuclear Cardiology

Volumn 3, Issue 6 PART II, 1996, Pages

  Cerqueira, Manuel D ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; DYNAMIC EXERCISE; EXERCISE TEST; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; INTERMETHOD COMPARISON; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; STRESS;

CORONARY CIRCULATION; CORONARY DISEASE; DIAGNOSTIC IMAGING; EXERCISE TEST; EXERTION; HUMANS; MYOCARDIAL ISCHEMIA; VASODILATOR AGENTS;

EID: 0030455637     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1071-3581(96)90202-0     Document Type: Article

References (13)

1. Kiat H, Iskandrian AS, Villegas BJ, Starling MR, Berman DS, for The International Arbutamine Study Group. Arbutamine stress thallium-201 single-photon emission computed tomography using a computerized closed-loop delivery system: multicenter trial for evaluation of safety and diagnostic accuracy. J Am Coll Cardiol 1995;26:1159-67.
2. Marwick TH. Arbutamine stress testing with closed-loop drug delivery: toward the ideal or just another pharmacologic stress technique? [editorial]. J Am Coll Cardiol 1995;26:1176-9.
3. Cerqueira MD, Verani MS, Schwaiger M, Heo J, Iskandrian AS. Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol 1994;23:384-9.
4. Lette J, Tatum J, Fraser S, Miller D, Waters D, Heller G, et al. Safety of dipyridamole testing in 73,806 patients: the Multicenter Dipyridamole Safety Study. J Nucl Cardiol 1995;2:3-17.
5. Schlant R, Blomqvist C, Brandenburg R, DeBusk R, Ellestad M, Fletcher G, et al. Guidelines for exercise testing: a report of the American College of Cardiology/American Heart Association Task Force on assessment of cardiovascular procedures. J Am Coll Cardiol 1986;8:725-38.
6. Fletcher G, Froelicher V, Hartley L, Haskell W, Pollock M. Exercise standards: a statement for health professionals from the American Heart Association. Circulation 1990;82:2286-321.
7. Brown K, O'Meara J, Chambers C. Ability of dipyridamolethallium-201 imaging 1 to 4 days after acute myocardial infarction to predict in-hospital and late recurrent myocardial ischemic events. Am J Cardiol 1990;65:160-7.
8. Mahmarian JJ, Pratt CM, Nishimura S, Abreu A, Verani MS. Quantitative adenosine 201T1 single-photon emission computed tomography for the early assessment of patients surviving acute myocardial infarction. Circulation 1993;87:1197-210.
9. Mahmarian JJ, Mahmarian AC, Marks GF, Pratt CM, Verani MS. Role of adenosine thallium-201 tomography for denning long-term risk in patients after acute myocardial infarction. J Am Coll Cardiol 1995;25:1333-40.
10. Iskandrian AS, Heo J, Kong B, Lyons E. Effect of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: analysis of 461 patients. J Am Coll Cardiol 1989;14:1477-86.
11. Jacobson AF, Cerqueira MD, Raisys V, Shattuc S. Serum caffeine levels after 24 hours of caffeine abstention: observations on clinical patients undergoing myocardial perfusion imaging with dipyridamole or adenosine. Eur J Nucl Med 1994;21:23-6.
12. Brown KA, Altland E, Rowen M. Prognostic value of normal technetium-99m-sestamibi cardiac imaging. J Nucl Med 1994;35:554-7.
13. Brown KA, Rowen M. Prognostic value of a normal exercise myocardial perfusion imaging study in patients with angiographically significant coronary artery disease. Am J Cardiol 1993;71:865-7.